Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Network San Marino.
Press releases published on September 8, 2025
DPP1 Inhibitor Market Set to Reach New Heights in the Coming Decade | DelveInsight
GlobeNewswire
·
September 8, 2025
New York, USA, Sept. 08, 2025 (GLOBE NEWSWIRE) -- DPP1 Inhibitor Market Set to Reach New Heights in the Coming Decade | DelveInsight The DPP1 inhibitor market is experiencing significant growth, driven by the recent BRINSUPRI approval for non-cystic …
RadNet, Inc. to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9th, 2025
GlobeNewswire
·
September 8, 2025
LOS ANGELES, Sept. 08, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced …
Press Release : Sequana Medical Announces New Share Capital Amount and New Number of Shares
GlobeNewswire
·
September 8, 2025
SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES Ghent, Belgium, 8 September 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of drug-resistant fluid overload …
OSE Immunotherapeutics Provides Update on Ongoing Proceedings Ahead of Shareholders’ Annual General Meeting of September 30, 2025
GlobeNewswire
·
September 8, 2025
OSE Immunotherapeutics Provides Update on Ongoing Proceedings Ahead of Shareholders’ Annual General Meeting of September 30, 2025 NANTES, France, September 8, 2025, 6p.m. CET – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) announces that, …
OSE Immunotherapeutics fait le point sur les procédures en cours avant l’Assemblée Générale Annuelle des actionnaires du 30 septembre 2025
GlobeNewswire
·
September 8, 2025
OSE Immunotherapeutics fait le point sur les procédures en cours avant l’Assemblée Générale Annuelle des actionnaires du 30 septembre 2025 NANTES, France – 8 septembre 2025, 18 heures – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) annonce qu’ …
Idorsia highlights very low real-world abuse potential of DORA class for insomnia treatment at WSC 2025
GlobeNewswire
·
September 8, 2025
Analysis of the FAERS database shows that the real-world abuse potential of the DORA class is very low and markedly less than those seen for other scheduled and non-scheduled insomnia therapies Allschwil, Switzerland – September 8, 2025 Idorsia Ltd (SIX: …
BIO CEO John Crowley to Receive Prestigious Dennis K. Stone Award at BioNTX iC³® Summit
GlobeNewswire
·
September 8, 2025
DALLAS, Sept. 08, 2025 (GLOBE NEWSWIRE) -- BioNTX proudly announces that John Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), has been named the 2025 recipient of the Dennis K. Stone Award, the highest recognition bestowed by …
Blue Cross and Blue Shield of Minnesota Announces New Leaders for Commercial Markets and Pharmacy
GlobeNewswire
·
September 8, 2025
EAGAN, Minn., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Blue Cross and Blue Shield of Minnesota (Blue Cross) today announced the appointment of Erin Barney as President of Commercial Markets and Jamie Reuter as Vice President of Pharmacy Solutions. Both leaders …
Unboxing Freshness: Chopped Leaf Catering Makes Serving Healthy Food Easier Than Ever
GlobeNewswire
·
September 8, 2025
Oakville, Ontario, Canada, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Chopped Leaf is unveiling a fresh take on catering this September with new portable catering boxes that make it easier than ever to serve healthy, feel-good meals for any occasion. Designed for …
Prenetics’ IM8 Congratulates Global Ambassador and Shareholder - World No. 1 Aryna Sabalenka on Defending Her US Open Championship
GlobeNewswire
·
September 8, 2025
Aryna Sabalenka becomes first woman to defend US Open title in more than a decade AI-powered Aryna Sabalenka ad goes viral with 233M Instagram views and Times Square billboard during US Open IM8 achieves 300,000+ customer purchases and 6 million servings …
Erste Zwischenergebnisse aus BioNTechs und BMS‘ globaler Phase-2-Studie mit bispezifischem PD-L1xVEGF-A-Antikörperkandidat Pumitamig (BNT327/BMS986545) zeigen ermutigende Anti-Tumor-Aktivität bei fortgeschrittenem kleinzelligem Lungenkrebs
GlobeNewswire
·
September 8, 2025
Daten zur Kombination des bispezifischen PD-L1xVEGF-A-Antikörper-Kandidaten Pumitamig (BNT327/BMS986545) mit Chemotherapie zeigen weiterhin ermutigende Anti-Tumor-Aktivitäten bei Patientinnen und Patienten mit kleinzelligem Lungenkrebs im fortgeschrittenen …
First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity
GlobeNewswire
·
September 8, 2025
PD-L1xVEGF-A bispecific antibody pumitamig (BNT327/BMS986545) plus chemotherapy continues to show encouraging antitumor activity in patients with extensive-stage small cell lung cancer (”ES-SCLC”), expanding evidence for its potential to set a new standard …
KFSHRC Launches Middle East’s First Smart Neuroscience Ward With Electromagnetic Shielding for Ultra-Precise Brain Monitoring
GlobeNewswire
·
September 8, 2025
RIYADH, Saudi Arabia, Sept. 08, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital …
Vita Coco Unveils the “Concrete Jungle Gym” Experience in Brooklyn, Empowering Attendees to Break a Sweat and Recharge with Coconut Water, The Better Fitness Fuel™
GlobeNewswire
·
September 8, 2025
NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Vita Coco (NASDAQ:COCO), America’s leading coconut water brand, announced today that it will bring the Concrete Jungle Gym, an immersive pop-up fitness experience, to Domino Square in Brooklyn from September …
PsyCan Discovers Sharp Decline in Health Canada Approvals for Doctors Seeking Legal Psychedelic Therapy for Patients
GlobeNewswire
·
September 8, 2025
TORONTO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- PsyCan, the trade association representing Canada’s medical psychedelics industry, is calling for urgent reforms to the way Canadians access psychedelics for medical purposes following a release of Health Canada …
Streamex Exchange Corp NASDAQ-BSGM Creates a Tokenized Yield-Bearing Gold Product Generating up-to 4% through Exclusive Partnership with Monetary Metals
GlobeNewswire
·
September 8, 2025
Partnership unlocks exclusive tokenization rights, a four percent (4%) annual yield target on physical bullion, revenue share tied to leasing volumes and the creation of a groundbreaking institutionalized asset providing yield on physical gold holdings Key …
Novatio Solutions Strengthens European Presence with New Office in Germany
GlobeNewswire
·
September 8, 2025
MANNHEIM, Germany, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Novatio Solutions, a niche consulting and implementation partner specializing in Supply Chain Transformation and AI, has officially expanded its global footprint with the opening of its new office in …
BlueGenesLab Expands Genetic Panel to Include Three New GLP-1–Related Genes
GlobeNewswire
·
September 8, 2025
SCOTTSDALE, Ariz., Sept. 08, 2025 (GLOBE NEWSWIRE) -- BlueGenesLab, a precision genomics company headquartered in Scottsdale, Arizona, today announced the addition of three genes to its clinical testing panel that influence GLP‑1 (glucagon‑like peptide‑1) …
Tevogen Values TVGN-489 at $9–$11 Billion rNPV, Its First Clinical Product From the Proprietary ExacTcell™ Allogeneic T Cell Platform
GlobeNewswire
·
September 8, 2025
WARREN, N.J., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today shared the risk-adjusted net present value (rNPV) estimate of $9 billion to $11 billion for TVGN-489, an allogeneic precision T cell …
New 4-Year Data for Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) Presented at ICIEM
GlobeNewswire
·
September 8, 2025
PRINCETON, N.J., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), today announced the presentation of new 4-year muscle function, muscle strength and biomarker endpoints from the PROPEL open-label extension (OLE) study of …